John E. Burke - Apr 7, 2022 Form 4 Insider Report for BLONDER TONGUE LABORATORIES INC (BDRL)

Role
Director
Signature
/s/ John E.Burke by Eric Skolnik Under Power of Attorney
Stock symbol
BDRL
Transactions as of
Apr 7, 2022
Transactions value $
$0
Form type
4
Date filed
4/8/2022, 04:50 PM
Previous filing
Dec 20, 2021
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDRL Stock Option (right to buy) Award $0 +20K $0.00 20K Apr 7, 2022 Common Stock par value $0.001 20K $0.57 Direct F1, F2, F3
transaction BDRL Stock Option (right to buy) Award $0 +20K $0.00 20K Apr 7, 2022 Common Stock par value $0.001 20K $0.57 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was granted under the 2016 Director Equity Incentive Plan.
F2 The exercise price equals the fair market value (equal to the closing price as reported on the NYSE American) of the common stock on the grant date.
F3 The stock option vests on the first anniversary of the grant date.
F4 The stock option was granted under the 2016 Director Equity Incentive Plan.
F5 The exercise price equals the fair market value (equal to the closing selling price as reported on the NYSE American) of the common stock on the grant date.
F6 The stock option vests on 09/30/22.